Hjem › Pladecellekarcinom › Georgia › Atlanta
Pladecellekarcinom kliniske forsøg i Atlanta, GA
5 studier for Pladecellekarcinom søger deltagere på steder i og omkring Atlanta (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
RekruttererFase 3
- Emory University Hospital Midtown, Atlanta
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
RekruttererFase 2
- Winship Cancer Institute at Emory University, Atlanta
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
RekruttererFase 1/2
- Winship Cancer Institute - Emory University, Atlanta
Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised Patients
Rekrutterer
- Emory University, Atlanta
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
RekruttererFase 3
- Emory University, Atlanta
Pladecellekarcinom forsøg i andre byer
- Pittsburgh, PA10 studier
- Los Angeles, CA8 studier
- Boston, MA8 studier
- Houston, TX7 studier
- New York City, NY7 studier
- Nashville, TN7 studier
- Durham, NC4 studier
- Arlington, VA4 studier
- Tampa, FL4 studier
- Orlando, FL4 studier
- Queens, NY4 studier
- Washington, DC4 studier
Andre studier i Atlanta
- Kræft (alle typer)49 studier
- Ikke-småcellet lungecancer47 studier
- Brystkræft41 studier
- Multipelt myelom41 studier
- Prostatakræft33 studier
- Akut myeloid leukæmi30 studier
- Ægstockræft29 studier
- Lungecancer29 studier
- Colorektal kræft29 studier
- Metastatisk cancer28 studier
- Hjertesvigt25 studier
- Alvorlig depressiv lidelse25 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.